CareLit · DOI-Nachweis · Pneumologie
Effects of tezacaftor/ivacaftor (TEZ/IVA) treatment in patients with cystic fibrosis and F508del/F508del-CFTR: patient-reported outcomes in a Phase 3, randomised, controlled trial (EVOLVE)
DOI 10.1055/s-0039-1678165
Bibliografische Angaben
Nachweis in CareLit
Autor:innenO Sommerburg, Y Yang, AA Rizio, B Loop, X You, M Kosinski, R Rendas-Baum, J Lekstrom-Himes, JS Elborn
ZeitschriftPneumologie
AusgabeS 01 S 01/2019
Jahrgang / SeitenJg. 73
Kernaussage aus der Literatur
Abstract-Vorschau
Effects of tezacaftor/ivacaftor (TEZ/IVA) treatment in patients with cystic fibrosis and F508del/F508del-CFTR: patient-reported outcomes in a Phase 3, randomised, controlled trial (EVOLVE)
Zitieren
Zitierempfehlung
O Sommerburg, Y Yang, AA Rizio, B Loop, X You, M Kosinski, R Rendas-Baum, J Lekstrom-Himes, JS Elborn (2019) Effects of tezacaftor/ivacaftor (TEZ/IVA) treatment in patients with cystic fibrosis and F508del/F508del-CFTR: patient-reported outcomes in a Phase 3, randomised, controlled trial (EVOLVE). Pneumologie, 73 (S 01 S 01). https://doi.org/10.1055/s-0039-1678165
Mit CareLit weiterarbeiten